文献速递免疫规划传染病防控与疫情报告

高度接种疫苗人群中腮腺炎发病率、住院及严重并发症的年龄组间转移:西班牙,1998-2014年

Shift within age-groups of mumps incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998-2014.
PubMed 文献 · Vaccine · 2017-07-04

研究分析了西班牙1998-2014年三波腮腺炎疫情,采用泊松回归识别易感人群变化。1998-2003年1-4岁组发病率最高(71.7例/10万),2004-2009和2010-2014年15-24岁和25-34岁组发病风险增加。住院率、并发症率和神经系统并发症率总体下降,但25-34岁组上升。

要点

  • 腮腺炎病例从儿童转向青少年和年轻成人,15-24岁和25-34岁组发病风险增加。
  • 住院率、并发症率和神经系统并发症率在住院患者中总体下降,但25-34岁组上升。
  • 低接种覆盖率时期出生及接种Rubini株疫苗的队列是受影响最严重的人群。

核心结论

  • 西班牙腮腺炎发病率增加,但住院和严重并发症总体减少。
  • 腮腺炎病例从儿童转向青少年和年轻成人,提示疫苗免疫力减弱。
  • 低接种覆盖率时期出生和接种Rubini株疫苗的队列是受影响最严重的人群。
  • 疫苗虽不能预防所有腮腺炎病例,但似乎能预防严重形式的疾病。

研究设计与样本

  • 研究分析了西班牙1998-2014年三波腮腺炎疫情,使用泊松回归识别易感人群变化。

主要发现

  • 1998-2003年(P1)1-4岁组发病率最高,为71.7例/10万。
  • 2004-2009年(P2)15-24岁组发病率比(IRR)为1.46,25-34岁组为2.17。
  • 2010-2014年(P3)15-24岁组IRR为2.68,25-34岁组为4.05。
  • 住院患者中,25-34岁组住院率比(HRR)P2=2.18、P3=2.16,并发症率比(CRR)P3=2.48,神经系统并发症率比(NRR)P3=2.41。

关键数值与推荐

  • 1998-2003年1-4岁组发病率71.7例/10万。
  • 2004-2009年15-24岁组IRR=1.46,25-34岁组IRR=2.17。
  • 2010-2014年15-24岁组IRR=2.68,25-34岁组IRR=4.05。
  • 25-34岁组HRR P2=2.18、P3=2.16;CRR P3=2.48;NRR P3=2.41。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The mumps vaccine (Jeryl-Lynn-strain) was introduced in Spain in 1981, and a vaccination policy which included a second dose was added in 1995. From 1992-1999, a Rubini-strain based vaccine was administered in many regions but later withdrawn due to lack of effectiveness. Despite high levels of vaccination coverage, epidemics have continued to appear. We characterized the three epidemic waves of mumps between 1998 and 2014, identifying major changes in susceptible populations using Poisson regression. For the period 1998-2003 (P1), the most affected group was from 1 to 4years old (y) [Incidence Rate (IR)=71.7 cases/100,000 population]; in the periods 2004-2009 (P2) and 2010-2014 (P3) IR ratio (IRR) increased among 15-24y (P2=1.46; P3=2.68) and 25-34y (P2=2.17; P3=4.05). Hospitalization rate (HR), complication rate (CR) and neurological complication rate (NR) among hospitalized subjects decreased across the epidemics, except for 25-34y which increased: HR ratio (HRR) (P2=2.18; P3=2.16), CRR (P3=2.48), NRR (P3=2.41). In Spain mumps incidence increased, while an overall decrease of hospitalizations and severe complications occurred across the epidemics. Cohorts born during periods of low vaccination coverage and those vaccinated with Rubini-strain were the most affected populations, leading to a shift in mumps cases from children to adolescents and young adults; this also reveals the waning immunity provided by the mumps vaccine. Despite not preventing all mumps cases, the vaccine appears to prevent serious forms of the disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. López-Perea N, Masa-Calles J, Torres de Mier MV, et al. Shift within age-groups of mumps incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998-2014. Vaccine. 2017. PMID: 28687402. doi:10.1016/j.vaccine.2017.06.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。